Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Eszopiclone (Lunesta) on Sleep Disturbance and Pain in Cancer.

Trial Profile

Effect of Eszopiclone (Lunesta) on Sleep Disturbance and Pain in Cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jul 2016

At a glance

  • Drugs Eszopiclone (Primary)
  • Indications Pain; Sleep disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2011 Results published in Supportive Care in Cancer.
    • 24 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Dec 2009 Primary endpoint 'Sleep-measures' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top